Next Article in Journal
Determination of the structure of a new nanoscaled ultrasound contrast agent
Previous Article in Journal
Numerical Simulation of Drop Impact on Wetted and Dry Surfaces
Article Menu

Article Versions

Export Article

Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2015). Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence. Articles are hosted by MDPI on as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Open AccessConference Report
Sci. Pharm. 2010, 78(3), 569; (registering DOI)

Magnetoliposomes: Liposomal Contrast Agents

Institute of Biophysics and Nanosystems Research, Austrian Academy of Sciences, Graz, 8042, Austria
Institute of Medical Engineering, University of Technology, Graz, 8010, Austria
Medical University, Graz, 8010, Austria
Author to whom correspondence should be addressed.
Received: 12 July 2010 / Accepted: 12 July 2010 / Published: 12 July 2010
PDF [133 KB, uploaded 29 September 2016]


Magnetoliposomes (MLs) are phospholipid vesicles encapsulating magnetic nanoparticles utilised as contrast agents for targeted molecular Magnetic Resonance Imaging (MRI). [...]
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

FRASCIONE, D.; SABA-LEPEK, M.; DIWOKY, C.; OPRIESSNIG, P.; STOLLBERGER, R.; ALMER, G.; MANGGE, H.; PRASSL, R. Magnetoliposomes: Liposomal Contrast Agents. Sci. Pharm. 2010, 78, 569.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics



[Return to top]
Sci. Pharm. EISSN 2218-0532 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top